Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals, Inc. financial statements

Eledon Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 45.62M10-K
Cash and equivalentsUSD 22.81M10-Q
Total debtUSD 010-K

Eledon Pharmaceuticals, Inc. financials on 6ix · Eledon Pharmaceuticals, Inc. on 6ix